Eli Lilly (LLY) recently entered a collaboration with Gate Bioscience to develop molecular gate therapeutics, a move that ...

Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new ...

News provided by Gate Bioscience Nov 01, 2023, 8:00 AM ET Company Backed by $60M Series A Financing from Versant Ventures, a16z Bio + Health, ARCH Venture Partners, and GV ...

Gate Bioscience is creating a new class of medicines called Molecular Gates, small molecules that selectively eliminate harmful extracellular proteins at their origin: inside the cell.

Gate Bioscience Inc., a new (ish) company with a new class of drugs in the works, emerged from stealth mode and disclosed a $60 million series A financing led by Versant Ventures and A16z Bio + Health ...

BRISBANE, Calif., Nov. 1, 2023 /PRNewswire/ -- Gate Bioscience, a biotechnology company creating a new class of medicines called Molecular Gates, today unveiled the company and its scientific ...